Intra Cellular Therapies reported $-68744000 in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -43.87M 22.58M
ALKERMES ALKS:US $ 2.36M 24.78M
Aptinyx Inc APTX:US $ -19819000 5.59M
Arena Pharmaceuticals ARNA:US $ -146.1M 27.68M
Biocryst Pharmaceuticals BCRX:US $ -43.2M 21.09M
Biogen BIIB:US $ 329.2M 119.3M
Bristol Myers Squibb BMY:US $ 1055M 966M
Cytokinetics CYTK:US $ -61.55M 14.45M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
Gilead Sciences GILD:US $ 1522M 207M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Halozyme Therapeutics HALO:US $ 91.46M 63.56M
Intra Cellular Therapies ITCI:US $ -68.74M 16M
JAZZ PHA JAZZ:US $ -363.32M 485.15M
Johnson & Johnson JNJ:US $ 3667M 2611M
Marinus Pharmaceuticals MRNS:US $ -23.82M 3.32M
Minerva Neurosciences NERV:US $ -10.59M 1.78M
Nektar Therapeutics NKTR:US $ -125.52M 2.55M
Neurocrine Biosciences NBIX:US $ 42.3M 10.2M
Novartis NVS:US $ 2758M 138M
Prothena PRTA:US $ 27.64M 64.38M
Redhill Biopharma RDHL:US $ -29.12M 6.26M
Supernus Pharmaceuticals SUPN:US $ 23.73M 18.03M
United Therapeutics UTHR:US $ 172.6M 144.3M
Vanda Pharmaceuticals VNDA:US $ 9.65M 1M
Zogenix ZGNX:US $ -58.9M 3.27M